Clinical Outcomes of Topical 0.1% Ciclosporin Cationic Emulsion Used on Label in Children with Vernal Keratoconjunctivitis-Reference-Cited by-同舟云学术

Clinical Outcomes of Topical 0.1% Ciclosporin Cationic Emulsion Used on Label in Children with Vernal Keratoconjunctivitis

Published:2023-04-12 Issue:3 Volume:12 Page:1787-1793
ISSN:2193-8245
Container-title:Ophthalmology and Therapy
language:en
Short-container-title:Ophthalmol Ther

Author:

Giannaccare Giuseppe^ORCID,Rossi Costanza,Borselli Massimiliano,Bonzano Chiara,Carnovale Scalzo Giovanna,Nicolò Massimo,Scorcia Vincenzo,Traverso Carlo Enrico,Vagge Aldo

Publisher

Springer Science and Business Media LLC

Subject

Ophthalmology

Link

https://link.springer.com/content/pdf/10.1007/s40123-023-00707-y.pdf

Reference19 articles.

1. Lallemand F, Daull P, Benita S, Buggage R, Garrigue J-S. Successfully improving ocular drug delivery using the cationic nanoemulsion, novasorb. 2012;2012:604204

2. Rojanasakul Y, Robinson JR. Transport mechanisms of the cornea: characterization of barrier permselectivity. Int J Pharm. 1989;55(2–3):237–46.

3. Lallemand F, Daull P, Benita S, Buggage R, Garrigue JS. Successfully improving ocular drug delivery using the cationic nanoemulsion, novasorb. J Drug Deliv. 2012;2012:604204. https://doi.org/10.1155/2012/604204.

4. Vandamme TF. Microemulsions as ocular drug delivery systems: recent developments and future challenges. Prog RetinEye Res. 2002;21:15e34.

5. European Medicines Agency. Verkazia. Annex 1: Summary of product characteristics (SmPC). https://www.ema.europa.eu/en/documents/product-information/verkazia-epar-product-information_en.pdf. Accessed 13 Nov 2019.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vernal Keratoconjunctivitis: Immunopathological Insights and Therapeutic Applications of Immunomodulators;Life;2024-03-09

2. Vernal Keratoconjunctivitis: A Systematic Review;Clinical Reviews in Allergy & Immunology;2023-09-02